MIF not only promotes fibroblast proliferation and stimulates neutrophil chemotaxis and Th17 cell differentiation by increasing the expression of TLR4, but it also enhances RANKL-induced osteoclastogenesis thereby aggravating bone erosion in RA (39–41). Here, MIF is linked to rheumatoid arthritis.